AHRQ releases new CME/CE activities
Research Activities, September 2011
The Agency for Healthcare Research and Quality (AHRQ) has released two new continuing medical education/continuing education (CME/CE) modules based on Comparative Effectiveness of Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease, a comparative effectiveness review developed by the Agency's Effective Health Care Program. The formats include a supplement to the electronic Journal of Managed Care Pharmacy and a video discussion.
The modules are available free of charge at CME/CE Activities .
A copy of the report and more information are available on AHRQ's Effective Health Care Program Web site.